AJP - Endo Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Endocrinol Metab 281: E375-E383, 2001;
0193-1849/01 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (12)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fosgerau, K.
Right arrow Articles by Bergman, R. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fosgerau, K.
Right arrow Articles by Bergman, R. N.
Vol. 281, Issue 2, E375-E383, August 2001

Lack of hepatic "interregulation" during inhibition of glycogenolysis in a canine model

K. Fosgerau1, S. D. Mittelman2, A. Sunehag3, M. K. Dea2, K. Lundgren1, and R. N. Bergman2

1 Department of Diabetes Biochemistry and Metabolism, Novo Nordisk, DK-2760 Maaloev, Denmark; 2 Department of Physiology and Biophysics, University of Southern California, Los Angeles, California 90033; and 3 Children's Nutrition Research Center, Houston, Texas 77030

It has been proposed that the glycogenolytic and gluconeogenic pathways contributing to endogenous glucose production are interrelated. Thus a change in one source of glucose 6-phosphate might be compensated for by an inverse change in the other pathway. We therefore investigated the effects of 1,4-dideoxy-1,4-imino-D-arabinitol (DAB), a potent glycogen phosphorylase inhibitor, on glucose production in fasted conscious dogs. When dogs were treated acutely with high glucagon, glucose production rose from 1.93 ± 0.14 to 3.07 ± 0.37 mg · kg-1 · min-1 (P < 0.01). When dogs were treated acutely with DAB in addition to high glucagon infusion, the stimulation of the glycogenolytic rate was completely suppressed. Glucose production rose from 1.85 ± 0.20 to 2.41 ± 0.17 mg · kg-1 · min-1 (P < 0.05), which was due to the increase in gluconeogenesis from 0.93 ± 0.09 to 1.54 ± 0.08 mg · kg-1 · min-1 (P < 0.001). In conclusion, infusion of DAB inhibited glycogenolysis; however, the absolute contribution of gluconeogenesis to glucose production was not affected. These results suggest that inhibition of glycogenolysis could be an effective antidiabetic treatment.

type 2 diabetes; glycogen phosphorylase; 1,4-dideoxy-1,4-imino-D-arabinitol


This article has been cited by other articles:


Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
P. Staehr, O. Hother-Nielsen, H. Beck-Nielsen, M. Roden, H. Stingl, J. J. Holst, P. K. Jones, V. Chandramouli, and B. R. Landau
Hepatic autoregulation: response of glucose production and gluconeogenesis to increased glycogenolysis
Am J Physiol Endocrinol Metab, May 1, 2007; 292(5): E1265 - E1269.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
C. C. Greenberg, M. J. Jurczak, A. M. Danos, and M. J. Brady
Glycogen branches out: new perspectives on the role of glycogen metabolism in the integration of metabolic pathways
Am J Physiol Endocrinol Metab, July 1, 2006; 291(1): E1 - E8.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
S. M. Gustavson, C. A. Chu, M. Nishizawa, B. Farmer, D. Neal, Y. Yang, S. Vaughan, E. P. Donahue, P. Flakoll, and A. D. Cherrington
Glucagon's actions are modified by the combination of epinephrine and gluconeogenic precursor infusion
Am J Physiol Endocrinol Metab, September 1, 2003; 285(3): E534 - E544.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
S. M. Gustavson, C. A. Chu, M. Nishizawa, B. Farmer, D. Neal, Y. Yang, E. P. Donahue, P. Flakoll, and A. D. Cherrington
Interaction of glucagon and epinephrine in the control of hepatic glucose production in the conscious dog
Am J Physiol Endocrinol Metab, April 1, 2003; 284(4): E695 - E707.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. Fosgerau, J. Breinholt, J. G. McCormack, and N. Westergaard
Evidence against Glycogen Cycling of Gluconeogenic Substrates in Various Liver Preparations
J. Biol. Chem., August 2, 2002; 277(32): 28648 - 28655.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online